Researchers have found a protein that seems to protect brain cells …
WEBJul 24, 2024 · A study of 48 post-mortem brains found a protein that appears to protect brain cells from Alzheimer's — even in people who had significant amounts of amyloid plaques in their brains.
FDA fully approves Leqembi, first drug shown to slow Alzheimer's ...
WEBJul 6, 2023 · The Food and Drug Administration has fully approved the first drug shown to slow down Alzheimer's disease. The action means that Leqembi, whose generic name is lecanemab, should be widely...
First Alzheimer’s drug to slow disease progression gets full FDA ...
WEBJul 7, 2023 · The US Food and Drug Administration on Thursday granted traditional full approval to the Alzheimer’s drug Leqembi, the first medicine proven to slow the course of the memory-robbing disease.
New Drug Approved for Early Alzheimer’s - The New York Times
WEBJul 2, 2024 · The Food and Drug Administration on Tuesday approved a new drug for Alzheimer’s disease, the latest in a novel class of treatments that has been greeted with hope, disappointment and skepticism.
A Blood Test Accurately Diagnosed Alzheimer’s 90% of the Time, …
WEBJul 28, 2024 · On Sunday, a team of researchers reported that a blood test was significantly more accurate than doctors’ interpretation of cognitive tests and CT scans in signaling the condition.
Second Alzheimer’s drug to slow disease’s progression may be ... - CNN
WEBJul 17, 2023 · Experimental Alzheimer’s drug slows cognitive declines in large trial, drugmaker Eli Lilly says. More than 6 million Americans are estimated to have Alzheimer’s disease, with about 1 million...
Leqembi and Alzheimer’s: What to Know About the New Drug, …
WEBJun 10, 2024 · Alzheimer’s is the most common form of dementia, but much remains unknown about this daunting disease. How is Alzheimer’s diagnosed? What causes …
Start of new era for Alzheimer’s treatment — Harvard Gazette
WEBJun 5, 2023 · Researchers say we appear to be at the start of a new era for Alzheimer’s treatment. Trial results published in January showed that for the first time a drug has been able to slow the cognitive decline characteristic of the disease.
FDA Grants Traditional Approval to Leqembi: Full Details | alz.org
WEBCHICAGO, July 6, 2023 — The Alzheimer’s Association celebrates today’s U.S. Food and Drug Administration (FDA) action to grant traditional approval of Leqembi® (lecanemab, Eisai/Biogen) for the treatment of early Alzheimer's disease with confirmation of …
With new therapies that promise to slow Alzheimer’s disease ...
WEBJul 16, 2023 · Under new draft guidelines for the diagnosis of Alzheimer’s disease, unveiled on Sunday at a large international gathering of physicians and researchers, these memory tests would take a...